Jim was one of four discussants on NPR’s “On Point” and coauthor of an editorial in JAMA
The “On Point” discussion, related to President Obama’s announcement regarding the Precision Medicine Initiative, is available as a . In the , Jim and Michael Watson of the ACMG Foundation for Genetic and Genomic Medicine argue against the proposed regulation of laboratory-developed diagnostic tests by the FDA.